The past decade has seen significant advances in the understanding of hidradenitis suppurativa pathogenesis, informing research into novel treatment approaches, such as biologics, and expanded indications for existing pharmacologic agents. Ali Alikhan, MD reviews the evolving landscape in HS and revolutions in treatment approaches.
In the second video in a series, Steven Cohen, MD talks about standard and new treatments for hidradenitis suppurativa. He talks to host Adam Friedman, MD about optimized regimens and long-term patient support.
Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.
With a surge in new research over the last decade, dermatologists are learning more about Hidradenitis Suppurativa, comorbidities, and quality of life impact. In the first of a series, Steven Cohen, MD discusses HS with host Adam Friedman, MD.
Kerecis Scores DoD Grant to Develop, Test New Fish-skin Wound Treatment for Soldiers
Patients with Chronic Conditions Who Experience Telehealth Rate it Higher than Those Who Have Not
DermWireTV: Cassiopeia Winlevi; Psoriasis Guidelines; Cyndi Lauper's PsO in the Know; Sarah Michelle Gellar's CoolSculpting
New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types
DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates
DermWireTV: Practices Reopen; Prescriber's Choice Expands; Sun Takes on Acne
FDA Approves Ortho Dermatologics' Jublia to Treat Onychomycosis in Patients As Young As Six Years Old
Can JAK Inhibition Put the Brakes on COVID-19-Associated Cytokine Storm? Incyte Hopes So
DermWire Exclusive: Inside the COVID-19 Outbreak in Italy with Dr. Sebastiano Recalcati
Lessons from Italy: Understanding and Recognizing Potential Skin Manifestations in COVID-19